Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 16 05 2023
revised: 28 05 2023
accepted: 27 06 2023
medline: 4 9 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

A vaccine targeting HER2, a nonmutated but overexpressed tumor antigen, readily primed T cells for ex vivo expansion and adoptive transfer with minimal toxicity. This regimen led to intramolecular epitope spreading in a majority of patients and offers a treatment modality that may improve outcomes for patients with metastatic breast cancer expressing HER2. See related article by Disis et al., p. 3362.

Identifiants

pubmed: 37428103
pii: 727705
doi: 10.1158/1078-0432.CCR-23-1244
pmc: PMC10472089
doi:

Substances chimiques

Cancer Vaccines 0
Receptor, ErbB-2 EC 2.7.10.1
Antigens, Neoplasm 0

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

3256-3258

Commentaires et corrections

Type : CommentOn

Informations de copyright

©2023 The Authors; Published by the American Association for Cancer Research.

Références

Cancer Immunol Res. 2019 Jul;7(7):1148-1161
pubmed: 31088845
Clin Cancer Res. 2022 Apr 14;28(8):1487-1492
pubmed: 34916216
Clin Cancer Res. 2019 May 1;25(9):2725-2736
pubmed: 30635338
Clin Breast Cancer. 2010 Oct 1;10(5):392-7
pubmed: 20920984
Clin Cancer Res. 2023 Sep 1;29(17):3362-3371
pubmed: 37093223
Clin Cancer Res. 2020 Sep 1;26(17):4670-4681
pubmed: 32732224
Breast. 2022 Dec;66:217-226
pubmed: 36334569
Nat Genet. 2020 Jul;52(7):701-708
pubmed: 32424352
Mol Ther. 2010 Apr;18(4):843-51
pubmed: 20179677
N Engl J Med. 2012 Jan 12;366(2):109-19
pubmed: 22149875
Lancet Oncol. 2022 Dec;23(12):1558-1570
pubmed: 36400106
Nat Commun. 2020 Oct 6;11(1):5017
pubmed: 33024122
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153

Auteurs

Erika J Crosby (EJ)

Department of Surgery, Duke University, Durham, North Carolina.

Zachary C Hartman (ZC)

Departments of Surgery, Integrative Immunobiology, and Pathology, Duke University, Durham, North Carolina.

H Kim Lyerly (HK)

Departments of Surgery, Integrative Immunobiology, and Pathology, Duke University, Durham, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH